Medical Market Report

Global Biosimilar Market By Type (Surgical Sealants, Homeostatic Agents, Adhesive Barriers, Soft-Tissue Attachments, Biological Mesh, Allograft, Xenografts, And Bone-Graft Substitution), By Application (Cardiovascular And Thoracic Surgery, Neurological And Spine Surgery, Orthopedic Surgery, Gynecology Surgery, General Surgery, And Others), By Region And Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends And Forecast 2020-2029

  • 133971
  • 12-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on Biosimilar Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global biosimilar market is segmented on the basis of Type, Application, and geography.
    The global Biosimilar market was valued at US$ XX.X Mn in 2018 and is projected to increase significantly at a CAGR of x.x% from 2019 to 2028.

    Biosimilar Market Scope:

    By type, the market is segmented into Human Growth Hormones, Monoclonal Antibodies, Insulin, Peptides, Erythropoietin, and Others. By Application, the market is divided into Oncology, Chronic and Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases, and Others.
    Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Allergan plc, BIOCAD, Biocon, BioXpress Therapeutics SA, Boehringer Ingelheim GmbH, Celltrion Inc., Coherus BioSciences, Inc, Dr. Reddy’s Laboratories Ltd., Genor BioPharma Co. Ltd, Intas Pharmaceuticals Limited, Novartis AG, Pfizer, Inc., and Reliance Life Sciences

    .

    Key Market Segments

    Type

    Human Growth Hormones
    Monoclonal Antibodies
    Insulin
    Peptides
    Erythropoietin
    Others

    Application

    Oncology
    Chronic and Autoimmune Diseases
    Growth Hormone Deficiency
    Infectious Diseases
    Others

    Key Market Players included in the report:

    Allergan plc
    BIOCAD
    Biocon
    BioXpress Therapeutics SA
    Boehringer Ingelheim GmbH
    Celltrion Inc.
    Coherus BioSciences, Inc
    Dr. Reddy’s Laboratories Ltd.
    Genor BioPharma Co. Ltd
    Intas Pharmaceuticals Limited
    Novartis AG
    Pfizer, Inc.
    Reliance Life Sciences

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis industry research (global industry trends) and Biosimilar Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Biosimilar Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Biosimilar Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Biosimilar Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Biosimilar Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Biosimilar Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Biosimilar sub-markets, depending on key regions (various vital states).
    To analyze Biosimilar Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Biosimilar Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2012 to 2018, and also prediction to 2028.
    Primary worldwide Biosimilar Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Biosimilar Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

    2.1. Key Findings by Major Segments
    
2.2. Top strategies by Major Players3. Global Biosimilar Market Overview
    

    3.1. Biosimilar Market Dynamics
    

    3.1.1. Drivers
    
3.1.2. Opportunities
    
3.1.3. Restraints
    
3.1.4. Challenges3.2. PESTLE Analysis
    
3.3. Opportunity Map Analysis
    
3.4. PORTER’S Five Forces Analysis
    
3.5. Market Competition Scenario Analysis
    
3.6. Product Life Cycle Analysis
    
3.7. Opportunity Orbits
    
3.8. Manufacturer Intensity Map4. Global Biosimilar Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

    4.1. Global Biosimilar Market Analysis by Type: Introduction
    
4.2. Market Size and Forecast by Region
    
4.3. Human Growth Hormones
    
4.4. Monoclonal Antibodies
    
4.5. Insulin
    
4.6. Peptides
    
4.7. Erythropoietin
    
4.8. Others5. Global Biosimilar Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

    5.1. Global Biosimilar Market Analysis by Application: Introduction
    
5.2. Market Size and Forecast by Region
    
5.3. Oncology
    
5.4. Chronic and Autoimmune Diseases
    
5.5. Growth Hormone Deficiency
    
5.6. Infectious Diseases
    
5.7. Others6. Global Biosimilar Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

    6.1. North America
    

    6.1.1. North America Biosimilar Market: Regional Trend Analysis
    

    6.1.1.1. US
    
6.1.1.2. Canada
    
6.1.1.3. Mexico
    

    6.2.1. Europe
    

    6.2.1. Europe Biosimilar Market: Regional Trend Analysis
    

    6.2.1.1. Germany
    
6.2.1.2. France
    
6.2.1.3. UK
    
6.2.1.4. Russia
    
6.2.1.5. Italy
    
6.2.1.6. Spain
    
6.2.1.7. Rest of Europe
    

    6.3. Asia-Pacific
    

    6.3.1. Asia-Pacific Biosimilar Market: Regional Trend Analysis
    

    6.3.1.1. China
    
6.3.1.2. Japan
    
6.3.1.3. Korea
    
6.3.1.4. India
    
6.3.1.5. Rest of Asia
    

    6.4. Latin America
    

    6.4.1. Latin America Biosimilar Market: Regional Trend Analysis
    

    6.4.1.1. Brazil
    
6.4.1.2. Argentina
    
6.4.1.3. Rest of Latin America
    

    6.5. Middle East and Africa
    

    6.5.1. Middle East and Africa Biosimilar Market: Regional Trend Analysis
    

    6.5.1.1. GCC
    
6.5.1.2. South Africa
    
6.5.1.3. Israel
    
6.5.1.4. Rest of MEA
    
7. Global Biosimilar Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

    7.1. Market Share Analysis
    
7.2. Company Profiles
    
7.3. Allergan plc
    

    7.3.1. Company Overview
    
7.3.2. Financial Highlights
    
7.3.3. Product Portfolio
    
7.3.4. SWOT Analysis
    
7.3.5. Key Strategies and Developments7.4. BIOCAD
    

    7.4.1. Company Overview
    
7.4.2. Financial Highlights
    
7.4.3. Product Portfolio
    
7.4.4. SWOT Analysis
    
7.4.5. Key Strategies and Developments7.5. Biocon
    

    7.5.1. Company Overview
    
7.5.2. Financial Highlights
    
7.5.3. Product Portfolio
    
7.5.4. SWOT Analysis
    
7.5.5. Key Strategies and Developments7.6. BioXpress Therapeutics SA
    

    7.6.1. Company Overview
    
7.6.2. Financial Highlights
    
7.6.3. Product Portfolio
    
7.6.4. SWOT Analysis
    
7.6.5. Key Strategies and Developments7.7. Boehringer Ingelheim GmbH
    

    7.7.1. Company Overview
    
7.7.2. Financial Highlights
    
7.7.3. Product Portfolio
    
7.7.4. SWOT Analysis
    
7.7.5. Key Strategies and Developments7.8. Celltrion Inc.
    

    7.8.1. Company Overview
    
7.8.2. Financial Highlights
    
7.8.3. Product Portfolio
    
7.8.4. SWOT Analysis
    
7.8.5. Key Strategies and Developments7.9. Coherus BioSciences, Inc
    

    7.9.1. Company Overview
    
7.9.2. Financial Highlights
    
7.9.3. Product Portfolio
    
7.9.4. SWOT Analysis
    
7.9.5. Key Strategies and Developments7.10. Dr. Reddy’s Laboratories Ltd.
    

    7.10.1. Company Overview
    
7.10.2. Financial Highlights
    
7.10.3. Product Portfolio
    
7.10.4. SWOT Analysis
    
7.10.5. Key Strategies and Developments7.11. Genor BioPharma Co. Ltd
    

    7.11.1. Company Overview
    
7.11.2. Financial Highlights
    
7.11.3. Product Portfolio
    
7.11.4. SWOT Analysis
    
7.11.5. Key Strategies and Developments7.12. Intas Pharmaceuticals Limited
    

    7.12.1. Company Overview
    
7.12.2. Financial Highlights
    
7.12.3. Product Portfolio
    
7.12.4. SWOT Analysis
    
7.12.5. Key Strategies and Developments7.13. Novartis AG
    

    7.13.1. Company Overview
    
7.13.2. Financial Highlights
    
7.13.3. Product Portfolio
    
7.13.4. SWOT Analysis
    
7.13.5. Key Strategies and Developments7.14. Pfizer, Inc.
    

    7.14.1. Company Overview
    
7.14.2. Financial Highlights
    
7.14.3. Product Portfolio
    
7.14.4. SWOT Analysis
    
7.14.5. Key Strategies and Developments7.15. Reliance Life Sciences
    

    7.15.1. Company Overview
    
7.15.2. Financial Highlights
    
7.15.3. Product Portfolio
    
7.15.4. SWOT Analysis
    
7.15.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.